Protective effects of thalidomide on pulmonary injuries in a rat model of paraquat intoxication

[1]  Qian Zhou,et al.  Effect of transforming growth factor-β1 on acute lung injury caused by paraquat. , 2014, Molecular medicine reports.

[2]  Ching-Heng Lin,et al.  Addition of Immunosuppressive Treatment to Hemoperfusion Is Associated with Improved Survival after Paraquat Poisoning: A Nationwide Study , 2014, PloS one.

[3]  K. Amirshahrokhi.  Anti-inflammatory effect of thalidomide in paraquat-induced pulmonary injury in mice. , 2013, International immunopharmacology.

[4]  Cheng-ye Sun,et al.  Analysis of paraquat intoxication epidemic (2002-2011) within China. , 2013, Biomedical and environmental sciences : BES.

[5]  G. Hong,et al.  [Effect of thalidomide in a mouse model of paraquat-induced acute lung injury and the underlying mechanisms]. , 2013, Zhonghua lao dong wei sheng zhi ye bing za zhi = Zhonghua laodong weisheng zhiyebing zazhi = Chinese journal of industrial hygiene and occupational diseases.

[6]  K. Amirshahrokhi,et al.  Thalidomide attenuates multiple low-dose streptozotocin-induced diabetes in mice by inhibition of proinflammatory cytokines. , 2012, Cytokine.

[7]  N. Buckley,et al.  Medical management of paraquat ingestion. , 2011, British journal of clinical pharmacology.

[8]  Yuan-chao Zhang,et al.  Role of growth factors in acute lung injury induced by paraquat in a rat model , 2011 .

[9]  Xiangdong Jian,et al.  Role of growth factors in acute lung injury induced by paraquat in a rat model. , 2011, Human & experimental toxicology.

[10]  E. Mazzon,et al.  THALIDOMIDE SUPPRESSES SCLEROSING ENCAPSULATING PERITONITIS IN A RAT EXPERIMENTAL MODEL , 2009, Shock.

[11]  A. Ahmed.  Protective effect of montelukast on paraquat-induced lung toxicity in rats. , 2009, Bioscience trends.

[12]  E. Abraham,et al.  Role of extracellular superoxide in neutrophil activation: interactions between xanthine oxidase and TLR4 induce proinflammatory cytokine production. , 2008, American journal of physiology. Cell physiology.

[13]  E. Mazzon,et al.  EFFECTS OF THALIDOMIDE IN A MOUSE MODEL OF CERULEIN-INDUCED ACUTE PANCREATITIS , 2007, Shock.

[14]  T. Nakano,et al.  Thalidomide Prevents Bleomycin-Induced Pulmonary Fibrosis in Mice1 , 2007, The Journal of Immunology.

[15]  Magda Melchert,et al.  The thalidomide saga. , 2007, The international journal of biochemistry & cell biology.

[16]  T. Otsuki,et al.  Mouse model of paraquat-poisoned lungs and its gene expression profile. , 2007, Toxicology.

[17]  P. An,et al.  Thalidomide in Rat Liver Cirrhosis: Blockade of Tumor Necrosis Factor-α via Inhibition of Degradation of an Inhibitor of Nuclear Factor-κB , 2006, Pathobiology.

[18]  T. Kondo,et al.  Gene expression of cytokines and growth factors in the lungs after paraquat administration in mice. , 2006, Legal medicine.

[19]  K. Mihara,et al.  Gene expression analysis of the lung following paraquat administration in rats using DNA microarray. , 2004, The Journal of toxicological sciences.

[20]  Sae-Yong Hong,et al.  Paraquat Intoxication in Korea , 2002, Archives of environmental health.

[21]  J. Haddad,et al.  Redox signaling-mediated regulation of lipopolysaccharide-induced proinflammatory cytokine biosynthesis in alveolar epithelial cells. , 2002, Antioxidants & redox signaling.

[22]  F. Ursini,et al.  Reactive oxygen species and proinflammatory cytokine signaling in endothelial cells: effect of selenium supplementation. , 2000, Free radical biology & medicine.

[23]  P. Haslett,et al.  Differential cytokine modulation and T cell activation by two distinct classes of thalidomide analogues that are potent inhibitors of TNF-alpha. , 1999, Journal of immunology.

[24]  P. Haslett,et al.  Thalidomide Costimulates Primary Human T Lymphocytes, Preferentially Inducing Proliferation, Cytokine Production, and Cytotoxic Responses in the CD8+ Subset , 1998, The Journal of experimental medicine.

[25]  E. Kovacs,et al.  Fibrogenic cytokines and connective tissue production , 1994, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[26]  R. D'Amato,et al.  Thalidomide is an inhibitor of angiogenesis. , 1994, Proceedings of the National Academy of Sciences of the United States of America.

[27]  G. Kaplan,et al.  Thalidomide selectively inhibits tumor necrosis factor alpha production by stimulated human monocytes , 1991, The Journal of experimental medicine.

[28]  P. An,et al.  Thalidomide in rat liver cirrhosis: blockade of tumor necrosis factor-alpha via inhibition of degradation of an inhibitor of nuclear factor-kappaB. , 2006, Pathobiology : journal of immunopathology, molecular and cellular biology.

[29]  H. Koch.  Thalidomide and congeners as anti-inflammatory agents. , 1985, Progress in medicinal chemistry.